Language
English
Publication Date
3-1-2023
Journal
Nature Reviews Microbiology
DOI
10.1038/s41579-022-00824-8
PMID
36324031
PMCID
PMC9628324
PubMedCentral® Posted Date
11-2-2022
PubMedCentral® Full Text Version
Post-print
Abstract
Global COVID-19 vaccine equity remains aspirational for much of the world. But the emergence of rapidly evolving SARS-CoV-2 variants provides new opportunities to correct past public policies, support local vaccine production and combat rising anti-vaccine aggression.
Keywords
Humans, SARS-CoV-2, COVID-19, Antibodies, Neutralizing, Antibodies, Viral, Public health, Infectious diseases, Vaccines, SARS-CoV-2
Published Open-Access
yes
Recommended Citation
Peter J Hotez, "SARS-CoV-2 Variants Offer a Second Chance To Fix Vaccine Inequities" (2023). Faculty and Staff Publications. 3613.
https://digitalcommons.library.tmc.edu/baylor_docs/3613
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Diseases Commons, Epidemiology Commons, Influenza Humans Commons, Influenza Virus Vaccines Commons, International Public Health Commons, Pediatrics Commons, Tropical Medicine Commons